BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2501896)

  • 1. Affinity purification of plasma proteins: characterization of six affinity matrices and their application for the isolation of human factor VIII.
    te Booy MP; Riethorst W; Faber A; Over J; König BW
    Thromb Haemost; 1989 Apr; 61(2):234-7. PubMed ID: 2501896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of the factor VIII/von Willebrand factor complex (VIII/vWf), with guanidinium-derivatized matrices.
    Saundry RH; Savidge GF
    Bioseparation; 1991; 2(3):177-86. PubMed ID: 1368084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of factor VIII/von Willebrand factor from human plasma on immobilized lentil lectin.
    Zhou FL; Burnouf-Radosevich M; Burnouf T
    Protein Expr Purif; 1994 Apr; 5(2):138-43. PubMed ID: 8054845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoaffinity purification of factor VIII complex.
    Hornsey VS; Griffin BD; Pepper DS; Micklem LR; Prowse CV
    Thromb Haemost; 1987 Feb; 57(1):102-5. PubMed ID: 3109055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen.
    Austen DE; Smith JK
    Thromb Haemost; 1982 Aug; 48(1):46-8. PubMed ID: 6813994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic characteristics of adsorbed human plasma proteins on vascular grafts and biomaterials.
    Pankowsky DA; Ziats NP; Topham NS; Ratnoff OD; Anderson JM
    J Vasc Surg; 1990 Apr; 11(4):599-606. PubMed ID: 2109103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel core fractionation process of human plasma by expanded bed adsorption chromatography.
    Lihme A; Hansen MB; Andersen IV; Burnouf T
    Anal Biochem; 2010 Apr; 399(1):102-9. PubMed ID: 19995544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
    Koedam JA; Meijers JC; Sixma JJ; Bouma BN
    J Clin Invest; 1988 Oct; 82(4):1236-43. PubMed ID: 2971673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to human procoagulant factor VIII.
    Rotblat F; Goodall AH; O'Brien DP; Rawlings E; Middleton S; Tuddenham EG
    J Lab Clin Med; 1983 May; 101(5):736-46. PubMed ID: 6403638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of small molecular forms of Factor VIII/von Willebrand factor from plasma.
    Perret BA; Furlan M; Beck EA
    Haemostasis; 1984; 14(4):289-95. PubMed ID: 6437941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of recombinant human B-domain-deleted factor VIII using anti-factor VIII monoclonal antibody selected by the surface plasmon resonance biosensor.
    Oh HK; Lee JM; Byun TH; Park SY; Kim YH
    Biotechnol Prog; 2001; 17(6):1119-27. PubMed ID: 11735450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on human factor VIII and its antibodies using radiolabelling and affinity chromatography.
    Kavanagh ML; Wood CN; Davidson JF
    Thromb Haemost; 1981 Jun; 45(3):267-71. PubMed ID: 6792739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein adsorption on histidyl-aminohexyl-Sepharose 4B. II. Application to the negative one-step affinity purification of human beta2-microglobulin and immunoglobulin G.
    Pitiot O; Nedonchelle E; Legallais C; Vijayalakshmi MA
    J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(2):173-82. PubMed ID: 11486826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and insolubilisation of human F VIII by affinity chromatography.
    Madaras F; Bell WR; Castaldi PA
    Haemostasis; 1978; 7(6):321-31. PubMed ID: 720954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale purification of factor VIII by affinity chromatography: optimization of process parameters.
    te Booy MP; Faber A; de Jonge E; Wolterink EP; Riethorst W; Beugeling T; Bantjes A; Over J; König BW
    J Chromatogr; 1990 Mar; 503(1):103-14. PubMed ID: 2111329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the purification and characterization of human factor 8.
    Marchesi SL; Shulman NR; Gralnick HR
    J Clin Invest; 1972 Aug; 51(8):2151-61. PubMed ID: 4626584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the procurement of coagulation factor VIII: selective precipitation of factor VIII with hydrophilic polymers.
    Farrugia A; Griffin B; Pepper D; Prowse C
    Thromb Haemost; 1984 Jul; 51(3):338-42. PubMed ID: 6437004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatography of the VIII/vWF complex on dextran sulphate sepharose.
    Harrison P; Saundry RH; Savidge GF
    Thromb Res; 1988 Apr; 50(2):295-304. PubMed ID: 2455942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A fast and simple method for obtaining specific anti-von Willebrand factor IgG].
    Carmona E; Llopis F; Aznar JA; Villanueva MJ; Jorquera JI; Sánchez-Cuenca JM
    Sangre (Barc); 1989 Feb; 34(1):63-6. PubMed ID: 2652344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.